Antiviral biotechnology stock Biotron (ASX:BIT) turned heads on the ASX this morning, after announcing that its lead drug candidate - ... Read More The post ASX Health Stocks: Biotron gets a boost with promising in vivo study for COVID-19 treatment appeared first on Stockhead.
